SPARC achieves enrollment goal in PROSEEK Phase 2 Parkinson’s trial

Sun Pharma Advanced Research Company Ltd. (SPARC) has announced the successful completion of patient enrollment for the PROSEEK study, a significant global Phase 2 clinical ... Read More